206 related articles for article (PubMed ID: 14654662)
1. Cognitive and behavioral development in maternal phenylketonuria offspring.
Waisbren SE; Azen C
Pediatrics; 2003 Dec; 112(6 Pt 2):1544-7. PubMed ID: 14654662
[TBL] [Abstract][Full Text] [Related]
2. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
[TBL] [Abstract][Full Text] [Related]
3. Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the International Maternal PKU Collaborative Study.
Widaman KF; Azen C
Pediatrics; 2003 Dec; 112(6 Pt 2):1537-43. PubMed ID: 14654661
[TBL] [Abstract][Full Text] [Related]
4. The Maternal Phenylketonuria International Study: 1984-2002.
Koch R; Hanley W; Levy H; Matalon K; Matalon R; Rouse B; Trefz F; Güttler F; Azen C; Platt L; Waisbren S; Widaman K; Ning J; Friedman EG; de la Cruz F
Pediatrics; 2003 Dec; 112(6 Pt 2):1523-9. PubMed ID: 14654658
[TBL] [Abstract][Full Text] [Related]
5. Role of nutrition in pregnancy with phenylketonuria and birth defects.
Matalon KM; Acosta PB; Azen C
Pediatrics; 2003 Dec; 112(6 Pt 2):1534-6. PubMed ID: 14654660
[TBL] [Abstract][Full Text] [Related]
6. Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy.
Rouse B; Azen C
J Pediatr; 2004 Feb; 144(2):235-9. PubMed ID: 14760268
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy experiences in the woman with mild hyperphenylalaninemia.
Levy HL; Waisbren SE; Güttler F; Hanley WB; Matalon R; Rouse B; Trefz FK; de la Cruz F; Azen CG; Koch R
Pediatrics; 2003 Dec; 112(6 Pt 2):1548-52. PubMed ID: 14654663
[TBL] [Abstract][Full Text] [Related]
8. Outcome at age 4 years in offspring of women with maternal phenylketonuria: the Maternal PKU Collaborative Study.
Waisbren SE; Hanley W; Levy HL; Shifrin H; Allred E; Azen C; Chang PN; Cipcic-Schmidt S; de la Cruz F; Hall R; Matalon R; Nanson J; Rouse B; Trefz F; Koch R
JAMA; 2000 Feb; 283(6):756-62. PubMed ID: 10683054
[TBL] [Abstract][Full Text] [Related]
9. The Maternal Phenylketonuria Project: a summary of progress and challenges for the future.
Clarke JT
Pediatrics; 2003 Dec; 112(6 Pt 2):1584-7. PubMed ID: 14654670
[TBL] [Abstract][Full Text] [Related]
10. [Embryonic pathology caused by maternal phenylketonuria. A cause of underdiagnosed mental retardation. A report of 8 cases].
Campistol Plana J; Arellano Pedrola M; Poo Argüelles P; Escofet Sotera C; Pérez Olarte P; Vilaseca Buscà MA
An Esp Pediatr; 1999 Aug; 51(2):139-42. PubMed ID: 10495499
[TBL] [Abstract][Full Text] [Related]
11. [The maternal phenylketonuria syndrom--still current problem].
Didycz B; Domagała L; Pietrzyk JJ
Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
[TBL] [Abstract][Full Text] [Related]
12. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.
Levy HL; Waisbren SE
N Engl J Med; 1983 Nov; 309(21):1269-74. PubMed ID: 6633585
[TBL] [Abstract][Full Text] [Related]
13. Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development.
Titze K; Koch S; Helge H; Lehmkuhl U; Rauh H; Steinhausen HC
Dev Med Child Neurol; 2008 Feb; 50(2):117-22. PubMed ID: 18177411
[TBL] [Abstract][Full Text] [Related]
14. Maternal hyperphenylalaninemia syndrome: neuropsychological evaluation of four subjects during childhood and adolescence.
Corsello G; Cicero L; Giuffrè M; La Grutta S; Piccione M; Pusateri F; Ciaccio M; Roccella M
Minerva Pediatr; 2006 Dec; 58(6):557-69. PubMed ID: 17093378
[TBL] [Abstract][Full Text] [Related]
15. International collaborative study of intracytoplasmic sperm injection-conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: cognitive and motor assessments.
Ponjaert-Kristoffersen I; Bonduelle M; Barnes J; Nekkebroeck J; Loft A; Wennerholm UB; Tarlatzis BC; Peters C; Hagberg BS; Berner A; Sutcliffe AG
Pediatrics; 2005 Mar; 115(3):e283-9. PubMed ID: 15741353
[TBL] [Abstract][Full Text] [Related]
16. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
17. Maternal phenylketonuria in Western Australia: pregnancy outcomes and developmental outcomes in offspring.
Ng TW; Rae A; Wright H; Gurry D; Wray J
J Paediatr Child Health; 2003 Jul; 39(5):358-63. PubMed ID: 12887666
[TBL] [Abstract][Full Text] [Related]
18. Research design, organization, and sample characteristics of the Maternal PKU Collaborative Study.
Koch R; Azen C; Friedman E; Hanley W; Levy H; Matalon R; Rouse B; Trefz F; Ning J; de la Cruz F
Pediatrics; 2003 Dec; 112(6 Pt 2):1519-22. PubMed ID: 14654657
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic position, maternal IQ, home environment, and cognitive development.
Tong S; Baghurst P; Vimpani G; McMichael A
J Pediatr; 2007 Sep; 151(3):284-8, 288.e1. PubMed ID: 17719939
[TBL] [Abstract][Full Text] [Related]
20. Maternal phenylketonuria: report from the United Kingdom Registry 1978-97.
Lee PJ; Ridout D; Walter JH; Cockburn F
Arch Dis Child; 2005 Feb; 90(2):143-6. PubMed ID: 15665165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
